fashion -WSS

fashion

author：knowledge 2025-08-24 05:25:43 - browse：6382

Two people run on the sugar-phosphate backbone of DNA while holding base pairs — in the lab coverage from STAT — Adobe

LONDON — Widespread genetic testing as well as the development of cutting-edge, customized genetic therapies have opened the door to treating many more inherited conditions than previously possible. A few recent cases, in which bespoke medicines were created for children with exceedingly rare mutations, have raised hopes for furthering the approach.

Now, researchers and government agencies in the U.K. are trying to figure out the nitty-gritty to replicate those early one-off successes for as many patients as possible — what sort of preclinical testing a tailor-made treatment needs to go through before being used, what regulatory thresholds each treatment needs to clear, and how to pay for these therapies.

“A lot of the barriers are no longer scientific — we can make these drugs,” said Matthew Wood, a professor of pediatrics at the University of Oxford. “It’s more about, can we make them at a cost that is reasonable enough? And can we get the regulators to reduce the barriers to doing this so that when a patient shows up, you can actually make a drug quickly enough to benefit that patient, rather than it costing huge amounts of money and taking two or three years to do it?”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Iran's president begins a rare visit to Africa 'to promote economic diplomacy'

WSS

Tommy Tuberville reverses his claim that white nationalists are unfairly labeled racist

Eliminate the waiting period for sterilization covered by Medicaid

There's no autism epidemic. It's an autism diagnosis epidemic

Merck drug for rare lung condition set for approval in U.S.

Steward Health Care has deal to sell doctor network to UnitedHealth

Why the world’s most expensive drug might be worth the price

entertainment

fashion

leisure time

Moonlake's readout produced a cash windfall. Risks remain

After half a century, Israel moves to evict squatter from his cave home on the beach

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Patient advocates debate FDA's accelerated approval process

Novavax promises a turnaround & Lilly roils the obesity market

FDA's naming rule on biosimilars has undermined competition

Walensky prepares to leave CDC — and Congress — behind

Steward Health Care has deal to sell doctor network to UnitedHealth

Walensky prepares to leave CDC — and Congress — behind

Decaf coffee targeted by food safety group under obscure FDA rule

Wikipedia

Vertex Pharmaceuticals may move headquarters in Boston

Giant panda gives birth to squirming, squealing healthy twin girls at South Korean theme park

Giant panda gives birth to squirming, squealing healthy twin girls at South Korean theme park

Antibody drugs appear effective. Now can we make enough of them?

Readout LOUD podcast: mifepristone case, GLP

States should stop sabotaging methadone treatment reform

Wikipedia

hotspot

focus

Wikipedia